Category: One-Hour Concurrent Session

Late-Breaking Studies Affecting Patient Outcomes II

(9980003-03) Methylprednisolone, IV Immunoglobulin, Tocilizumab, or Anakinra for Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS/MIS-C): Report From a Randomized, Controlled, Open-Label Platform Trial